Mezzion Pharma140410
Mezzion Pharma (140410) Insider Ownership Report, Oct 29, 2026
Filing date ·
Park Dong-hyeon, an executive of Mezzion Pharma (CEO), reported an increase of 1,940 shares in holdings of Mezzion Pharma stock.
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.